ID   Ed149.BT
AC   CVCL_GR71
SY   Ed149
DR   TOKU-E; 4008
DR   Wikidata; Q54831957
RX   PubMed=10448865;
RX   PubMed=10807250;
RX   PubMed=11950413;
CC   Characteristics: Early passage culture.
CC   Karyotypic information: 52,XY,+X,+Y,+del(1)(p21),dic(1;2)(q25;p24),+3,-16,+18,+20,+21,+mar (PubMed=10448865).
CC   Caution: Indicated as originating from a 49 year old at sampling in PubMed=11950413 and 45 year old in PubMed=10807250.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=10448865; DOI=10.1023/A:1006115608103;
RA   Farr-Jones M.A., Parney I.F., Petruk K.C.;
RT   "Improved technique for establishing short term human brain tumor
RT   cultures.";
RL   J. Neurooncol. 43:1-10(1999).
//
RX   PubMed=10807250; DOI=10.1097/00006123-200005000-00030;
RA   Parney I.F., Farr-Jones M.A., Chang L.-J., Petruk K.C.;
RT   "Human glioma immunobiology in vitro: implications for immunogene
RT   therapy.";
RL   Neurosurgery 46:1169-1178(2000).
//
RX   PubMed=11950413; DOI=10.1097/00006123-200205000-00027;
RA   Parney I.F., Farr-Jones M.A., Koshal A., Chang L.-J., Petruk K.C.;
RT   "Human brain tumor cell culture characterization after
RT   immunostimulatory gene transfer.";
RL   Neurosurgery 50:1094-1102(2002).
//